|
Dermatology Associations is now offering a
new innovation in lashes. LATISSE™ (bimatoprost
ophthalmic solution) 0.03% is the first and only
prescription treatment approved by the FDA for
inadequate or not having enough eyelashes,
growing them longer, fuller and darker.
LATISSE™ makes lash growth possible because
of its active ingredient: bimatoprost. Although
the precise mechanism of action is not known,
research suggests that the growth of eyelashes
occurs by increasing the percent of hairs in,
and the duration of, the anagen (or growth)
phase. Lashes can grow longer, thicker and
darker because bimatoprost can also prolong this
growth phase.
Clinically proven results you can see over
time, LATISSE™ is FDA approved and effective.
It's a once-a-day treatment you apply topically
to the base of your upper eyelashes. Patients in
a clinical trial saw results in as few as 8
weeks with full results after 12 to 16 weeks.
It's an innovation backed by research. While
LATISSE™ is a new treatment for inadequate or
not enough eyelashes, it was developed through
years of research by Allergan, a pharmaceutical
leader with over 60 years of expertise in
prescription eye care products. Ask your doctor
if LATISSE™ solution is right for you.
To learn more about Latisse, national news and resources, you can also visit
the following websites:
^ Top
|
